CO2019001402A2 - Método para prevenir o tratar la pérdida de la audición - Google Patents
Método para prevenir o tratar la pérdida de la audiciónInfo
- Publication number
- CO2019001402A2 CO2019001402A2 CONC2019/0001402A CO2019001402A CO2019001402A2 CO 2019001402 A2 CO2019001402 A2 CO 2019001402A2 CO 2019001402 A CO2019001402 A CO 2019001402A CO 2019001402 A2 CO2019001402 A2 CO 2019001402A2
- Authority
- CO
- Colombia
- Prior art keywords
- hearing loss
- prevent
- treat hearing
- preventing
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se relaciona con métodos para prevenir o tratar la pérdida de audición y métodos para prevenir o inhibir la degeneración de células ciliadas o la muerte de células ciliadas en un sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16184541 | 2016-08-17 | ||
PCT/EP2017/070683 WO2018033543A1 (en) | 2016-08-17 | 2017-08-15 | Method of preventing or treating hearing loss |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2019001402A2 true CO2019001402A2 (es) | 2019-02-19 |
Family
ID=56740115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2019/0001402A CO2019001402A2 (es) | 2016-08-17 | 2019-02-15 | Método para prevenir o tratar la pérdida de la audición |
Country Status (18)
Country | Link |
---|---|
US (1) | US20190209568A1 (es) |
EP (1) | EP3500258A1 (es) |
JP (1) | JP2019528273A (es) |
KR (1) | KR20190039142A (es) |
CN (1) | CN109562105A (es) |
AU (1) | AU2017313296A1 (es) |
BR (1) | BR112019003006A2 (es) |
CA (1) | CA3033887A1 (es) |
CL (1) | CL2019000410A1 (es) |
CO (1) | CO2019001402A2 (es) |
EA (1) | EA201990220A1 (es) |
IL (1) | IL264625A (es) |
MA (1) | MA45981A (es) |
MX (1) | MX2019001819A (es) |
PE (1) | PE20190421A1 (es) |
PH (1) | PH12019550015A1 (es) |
SG (1) | SG11201900776TA (es) |
WO (1) | WO2018033543A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202012775SA (en) * | 2018-07-13 | 2021-02-25 | Kinarus Ag | Combinations of ppar agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR240698A1 (es) | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
US5421818A (en) | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
TWI249401B (en) * | 1999-04-14 | 2006-02-21 | Takeda Chemical Industries Ltd | Agent for improving ketosis |
US20020151491A1 (en) * | 2000-11-28 | 2002-10-17 | Jian-Dong Li | Composition and method for treating the over-production of mucin in diseases such as otitis media using an inhibitor of MUC5AC |
HU229604B1 (en) | 2001-02-12 | 2014-02-28 | Hoffmann La Roche | 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them |
DE602004005238T2 (de) | 2003-11-13 | 2007-11-08 | F. Hoffmann-La Roche Ag | Hydroxyalkylsubstituierte pyrido-7-pyrimidin-7-one |
WO2005115527A2 (en) | 2004-05-24 | 2005-12-08 | Auris Medical, Llc. | Combined otic aspirator and medication dispenser |
CN101679211A (zh) | 2007-06-15 | 2010-03-24 | 霍夫曼-拉罗奇有限公司 | 用于制备3-氨基-戊-1,5-二醇的新方法 |
KR20170117083A (ko) * | 2015-02-11 | 2017-10-20 | 서포트-벤처 게엠베하 | 난청을 예방 또는 치료하는 방법 |
MY195671A (en) * | 2016-06-08 | 2023-02-03 | Support Venture Gmbh | Pharmaceutical Combinations for Treating Cancer |
-
2017
- 2017-08-15 EP EP17757503.2A patent/EP3500258A1/en not_active Withdrawn
- 2017-08-15 CA CA3033887A patent/CA3033887A1/en not_active Abandoned
- 2017-08-15 AU AU2017313296A patent/AU2017313296A1/en not_active Abandoned
- 2017-08-15 WO PCT/EP2017/070683 patent/WO2018033543A1/en unknown
- 2017-08-15 CN CN201780049505.9A patent/CN109562105A/zh active Pending
- 2017-08-15 JP JP2019508866A patent/JP2019528273A/ja not_active Withdrawn
- 2017-08-15 SG SG11201900776TA patent/SG11201900776TA/en unknown
- 2017-08-15 PE PE2019000369A patent/PE20190421A1/es unknown
- 2017-08-15 BR BR112019003006-9A patent/BR112019003006A2/pt not_active IP Right Cessation
- 2017-08-15 EA EA201990220A patent/EA201990220A1/ru unknown
- 2017-08-15 KR KR1020197004579A patent/KR20190039142A/ko not_active Application Discontinuation
- 2017-08-15 US US16/325,686 patent/US20190209568A1/en not_active Abandoned
- 2017-08-15 MX MX2019001819A patent/MX2019001819A/es unknown
- 2017-08-15 MA MA045981A patent/MA45981A/fr unknown
-
2019
- 2019-01-28 PH PH12019550015A patent/PH12019550015A1/en unknown
- 2019-02-03 IL IL264625A patent/IL264625A/en unknown
- 2019-02-14 CL CL2019000410A patent/CL2019000410A1/es unknown
- 2019-02-15 CO CONC2019/0001402A patent/CO2019001402A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
MA45981A (fr) | 2019-06-26 |
PE20190421A1 (es) | 2019-03-19 |
JP2019528273A (ja) | 2019-10-10 |
WO2018033543A1 (en) | 2018-02-22 |
CL2019000410A1 (es) | 2019-06-28 |
PH12019550015A1 (en) | 2019-07-24 |
EA201990220A1 (ru) | 2019-08-30 |
IL264625A (en) | 2019-02-28 |
EP3500258A1 (en) | 2019-06-26 |
US20190209568A1 (en) | 2019-07-11 |
CN109562105A (zh) | 2019-04-02 |
SG11201900776TA (en) | 2019-03-28 |
BR112019003006A2 (pt) | 2019-05-14 |
KR20190039142A (ko) | 2019-04-10 |
CA3033887A1 (en) | 2018-02-22 |
MX2019001819A (es) | 2019-06-13 |
AU2017313296A1 (en) | 2019-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017008129A2 (es) | Método para prevenir o tratar la pérdida de la audición | |
PH12019502724A1 (en) | Compositions for modulating c9orf72 expression | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
ZA201906236B (en) | Kits and methods for treating hair | |
HK1258825A1 (zh) | 用於治療多汗症的方法和組合物 | |
PL3402575T4 (pl) | Sposoby i kompozycje do traktowania zniszczonych włosów | |
EP3519058C0 (en) | HAIR TREATMENT COMPOSITIONS AND METHODS | |
ZA201900044B (en) | Tuberculosis compositions and methods of treating or preventing tuberculosis | |
HK1246791A1 (zh) | 用於預防或治療感覺毛細胞死亡的化合物和方法 | |
BR112018070497A2 (pt) | métodos e formulações farmacêuticas para tratamento de condições oculares | |
BR112017009000A2 (pt) | apilimod para uso no tratamento de melanoma | |
PH12017501022B1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
BR112018013269A2 (pt) | composições e métodos para a avaliação do risco de ocorrência do câncer | |
MX2021006326A (es) | Inhibidores de pcna. | |
HK1243635A1 (zh) | 治療皮膚病況的組合物和方法 | |
BR112017008097A2 (pt) | método para tratar condições oculares | |
IL290810A (en) | Agents for stem cell differentiation and cancer treatment | |
CO2019001402A2 (es) | Método para prevenir o tratar la pérdida de la audición | |
IL244247A0 (en) | Means and method for managing an investment portfolio | |
UA106529U (uk) | Спосіб терапії променевих опіків шкіри |